Asia shares slip on Brexit snag, Texas Instruments’ revenue woes
October 23, 2019Toyota’s luxury Lexus brand plans battery EV launch in 2020
October 23, 2019Biogen, Eisai revive plans for Alzheimer’s drug, surprising market
at
Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer’s treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients.
Powered by WPeMatico
